#India-US, #India-US, #December 2017

Indian companies created over 100,000 jobs in the US in recent months, which will define the relationship into the New Year.

Biocon widens BristolMyers Squibb tie-up

Biocon’s contract research arm, Syngene International, has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026.

Syngene International said in a Bombay Stock Exchange (BSE) filing: “The next phase of the partnership will see the addition of a new facility to support future Bristol-Myers Squibb research and development operations, an expansion of the team and the extension of the existing agreement through 2026.”

The expansion will enable the two companies to undertake a greater range of scientific research and development for pharmaceuticals across a broader range of activities.

Syngene’s new dedicated facility will be spread across 25,000 sq ft of laboratory and office space for Bristol-Myers Squibb. It will house an additional team of 75 Syngene scientists who will work exclusively for Bristol-Myers Squibb.

Biocon BMS Research Center (BBRC), Syngene’s first dedicated R&D centre, was established in 2007, which was subsequently renewed through 2020 and now has been extended till 2026.

It is the largest research and development facility for Bristol-Myers Squibb outside the United States and plays an integral part within their global research and development network.

#India-UK, #Yearend 2016

London attracts many of India’s new adventurers looking to expand globally. A trade and investment expert from the mayor’s team tells ‘India Global Business’ why that will continue to be the case in the New Year.

It is crucial London further strengthens ties with the great cities across India, because when it comes to business, we already share a special bond.

#October 2017, #THE AMERICAS

A US-based academic analyses how the Indian IT industry is coping with an intensifying squeeze on HI-B visas.

In recent months, the US government has been exerting pressure to curb the H-1B visa programme for companies that rely on them and is stressing the importance behind its Hire America policies. The H-1B programme has come under severe scrutiny, much to the concern of its biggest benefactors: Indian tech companies. Indian firms, however, are trying to adapt.

#March/April 2016, #Year, #2016, #Asia Pacific

Siddharth Jhunjhunwala, co-founder & CEO, & Kavita Jhunjhunwala, co-founder & Digital Lead, of Web Spiders set up their start-up in Kolkata in the early 2000s with just two computers and now have over 300 employees around the globe, with a co-located HQ in Singapore as well as bases in the US and UK. The Jhunjhunwalas relive their fascinating journey with ‘India Global Business’.